HCG Q1 FY27: consolidated PAT jumps sharply YoY

Profit growth above 25%Related-party transactionsExceptional itemResults View source PDF Explain this filing

HCG · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.6%Reaction day

₹674.00

prior close

₹670.10

announcement price

After-mkt

timing

Nifty Microcap 250market+0.0%+0.6% vs market

Hospital peers, median of 26sector+0.2%+0.4% vs sector

On the reaction day the stock moved 0.6 pts more than Nifty Microcap 250 and 0.4 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.3

10m

-1.0

15m

-1.5

30m

-1.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.6+0.0+0.6+0.2+0.4

Next day

+6.2-0.0+6.2-0.1+6.3

+8.1-0.2+8.3-0.4+8.6

+9.3+0.2+9.2-2.1+11.5

+7.1+0.3+6.8-3.0+10.1

+6.0+0.4+5.6-1.7+7.7

+5.8+0.9+4.9-1.6+7.3

15d

+3.1+1.6+1.5-3.1+6.1

+2.3+2.0+0.3-2.5+4.8

-2.4+0.6-2.9-10.4+8.1

—————

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 26Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

HCG reported Q1 FY27 standalone revenue of Rs 37,525 lakhs, up about 15% YoY, and consolidated revenue of Rs 69,339 lakhs, up about 13% YoY. Standalone PAT rose to Rs 558 lakhs versus Rs 345 lakhs, while consolidated PAT surged to Rs 1,646 lakhs versus Rs 598 lakhs. Board approved Rs 16 crore investment in HCG Rajkot subsidiary.

Likely market impact

Strong YoY profit growth signals improving profitability. Subsidiary investment and BACC divestment mark strategic shifts.